logo

Acorda Therapeutics Inc. (ACOR)



Trade ACOR now with
  Date
  Headline
7/26/2019 8:38:28 AM Acorda Gets Positive CHMP Opinion For INBRIJA
3/8/2019 7:08:09 AM Acorda Therapeutics Chief Business Officer Andrew Hindman To Transition Out Of Company Over Coming Months
9/13/2018 7:06:24 AM Acorda Therapeutics: FDA Extends PDUFA Goal Date For Review Of NDA Of INBRIJA From October 5, 2018 To January 5, 2019
5/29/2018 7:02:44 AM Acorda Announces EMA Validation Of The MAA Submission For INBRIJA
5/2/2018 6:06:56 AM Acorda Therapeutics Q1 GAAP Net Loss $8.2 Mln Or $0.18/Shr Vs Net Loss $18.9 Mln Or $0.41/Shr Last Year
3/26/2018 7:05:03 AM Acorda Files Marketing Authorization Application To EMA For INBRIJA
3/14/2018 6:03:00 AM Acorda Therapeutics Unveils “Live Well. Do Tell.” Initiative For Parkinson’s Disease Community
2/28/2018 7:07:28 AM Acorda Therapeutics Enters Into Cooperation Agreement With Scopia
2/20/2018 6:00:29 AM Acorda Announces FDA Acceptance Of New Drug Application For INBRIJA
  
 
>